Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study.

BMC Endocr Disord · 2014 · PMC3946132 · PMID 24593679

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

The use of dual antiplatelet therapy increased by borderline significance (4.8% vs. 3.1%, p = 0.06).

also in 7,017 other papers

highly significantno p-value reported

Indeed, when patients taking DPP-IV inhibitors and GLP-1 agonists were excluded (Table 4 ), the glucose-lowering prescription cost difference between 2006 and 2012 dropped to +25.3%, still highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.